626 related articles for article (PubMed ID: 25821314)
1. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
2. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
Adisa R; Omitogun TI
BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
4. Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.
Shukla S; Sharma P; Gupta P; Pandey S; Agrawal R; Rathour D; Kumar Kewat D; Singh R; Kumar Thakur S; Paliwal R; Sulakhiya K
Curr Drug Saf; 2024; 19(2):172-190. PubMed ID: 37132145
[TBL] [Abstract][Full Text] [Related]
5. Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital.
Chopra D; Wardhan N; Rehan HS
Int J Risk Saf Med; 2011; 23(4):227-32. PubMed ID: 22156087
[TBL] [Abstract][Full Text] [Related]
6. Pharmacovigilance Programme of India: Recent developments and future perspectives.
Kalaiselvan V; Thota P; Singh GN
Indian J Pharmacol; 2016; 48(6):624-628. PubMed ID: 28066097
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia.
Nadew SS; Beyene KG; Beza SW
PLoS One; 2020; 15(1):e0227712. PubMed ID: 31961883
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study.
Schutte T; Tichelaar J; Reumerman MO; van Eekeren R; Rolfes L; van Puijenbroek EP; Richir MC; van Agtmael MA
Drug Saf; 2017 May; 40(5):409-418. PubMed ID: 28120270
[TBL] [Abstract][Full Text] [Related]
9. Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis.
Terblanche A; Meyer JC; Godman B; Summers RS
Hosp Pract (1995); 2017 Dec; 45(5):238-245. PubMed ID: 28914115
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug reaction monitoring in a secondary care hospital in South India.
Arulmani R; Rajendran SD; Suresh B
Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
[TBL] [Abstract][Full Text] [Related]
11. Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.
Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
Drug Saf; 2005; 28(9):825-33. PubMed ID: 16119975
[TBL] [Abstract][Full Text] [Related]
12. A small economic inducement to stimulate increased reporting of adverse drug reactions--a way of dealing with an old problem?
Bäckström M; Mjörndal T
Eur J Clin Pharmacol; 2006 May; 62(5):381-5. PubMed ID: 16572320
[TBL] [Abstract][Full Text] [Related]
13. Parental reporting of adverse drug reactions in South Africa: An online survey.
Pillay S; Mulubwa M; Viljoen M
Afr J Prim Health Care Fam Med; 2021 Sep; 13(1):e1-e8. PubMed ID: 34636609
[TBL] [Abstract][Full Text] [Related]
14. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.
Figueiras A; Herdeiro MT; Polónia J; Gestal-Otero JJ
JAMA; 2006 Sep; 296(9):1086-93. PubMed ID: 16954488
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
[TBL] [Abstract][Full Text] [Related]
16. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
Jose J; Rao PG
Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
Aagaard L; Weber CB; Hansen EH
Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
[TBL] [Abstract][Full Text] [Related]
18. Nurses' Knowledge, Attitudes, and Practice in Relation to Pharmacovigilance and Adverse Drug Reaction Reporting: A Systematic Review.
Salehi T; Seyedfatemi N; Mirzaee MS; Maleki M; Mardani A
Biomed Res Int; 2021; 2021():6630404. PubMed ID: 33937402
[TBL] [Abstract][Full Text] [Related]
19. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review.
Fossouo Tagne J; Yakob RA; Dang TH; Mcdonald R; Wickramasinghe N
JMIR Public Health Surveill; 2023 Jan; 9():e40080. PubMed ID: 36645706
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with underreporting of adverse drug reactions by patients: a systematic review.
Costa C; Abeijon P; Rodrigues DA; Figueiras A; Herdeiro MT; Torre C
Int J Clin Pharm; 2023 Dec; 45(6):1349-1358. PubMed ID: 37247159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
